2015
DOI: 10.1136/heartjnl-2014-307351
|View full text |Cite
|
Sign up to set email alerts
|

Early discharge after transfemoral transcatheter aortic valve implantation

Abstract: Early discharge (within 72 h) after transfemoral TAVI is feasible and does not seem to jeopardise the early safety of the procedure, when performed in a subset of patients selected by clinical judgement. Patients undergoing TAVI in unstable haemodynamic compensation and patients experiencing bleeding after the procedure demonstrated to be poorly suitable to this approach, whereas increasing experience in post-TAVI management was associated with a reduction of LoS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
66
1
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 87 publications
(80 citation statements)
references
References 16 publications
11
66
1
2
Order By: Relevance
“…[5] and Barbanti et al [6] suggest that early discharge (≤ 3 days) is a feasible and safe option after TAVI. Factors associated with early discharge seem to be consistent in these studies and they overlap with predictors of "safe outcome".…”
Section: Discussionmentioning
confidence: 99%
“…[5] and Barbanti et al [6] suggest that early discharge (≤ 3 days) is a feasible and safe option after TAVI. Factors associated with early discharge seem to be consistent in these studies and they overlap with predictors of "safe outcome".…”
Section: Discussionmentioning
confidence: 99%
“…Elderly individuals experienced better in-hospital recovery and similar short-and mid-term mortality compared to those who underwent surgical aortic valve replacement [4]. Moreover, TAVI enables early rehabilitation and discharge [12,13].…”
Section: Discussionmentioning
confidence: 99%
“…In a retrospective study of 500 high-risk or inoperable patients who underwent transfemoral TAVI, >20 % were discharged within 72 hours and there were no differences in 30-day outcomes between the two groups. 27 Valve sizing has been a particularly controversial area in the recent past. After earlier attempts to measure the aortic annulus dimensions using 2D echocardiography, the current gold standard is a MDCT scan focussing on either area or perimeter measurement of the asymmetric annulus.…”
Section: -15mentioning
confidence: 99%